Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Cisplatin in Locally Advanced Cervical Carcinoma: NCT07055399 Clinical Landscape Report 2026
16 October 2026
NCT07055399 clinical landscape for Locally Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
NTRX-07 in Alzheimer Disease: NCT07058688 Clinical Landscape Report 2026
16 October 2026
NCT07058688 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Saruparib in Recurrent ovarian cancer: NCT07060365 Clinical Landscape Report 2026
16 October 2026
NCT07060365 clinical landscape for Recurrent ovarian cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Ovarian Cancer: NCT07059845 Clinical Landscape Report 2026
16 October 2026
NCT07059845 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Cervical Squamous Cell Carcinoma: NCT07061977 Clinical Landscape Report 2026
16 October 2026
NCT07061977 clinical landscape for Cervical Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Olaparib in BRCA-mutated Ovarian Cancer: NCT07069335 Clinical Landscape Report 2026
16 October 2026
NCT07069335 clinical landscape for BRCA-mutated Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GPC3/CD146 CAR-T cells(Essen Biotech) in Ovarian Carcinosarcoma: NCT07067255 Clinical Landscape Report 2026
16 October 2026
NCT07067255 clinical landscape for Ovarian Carcinosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anlotinib Dihydrochloride in Recurrent Platinum-Resistant Ovarian Carcinoma: NCT07075250 Clinical Landscape Report 2026
16 October 2026
NCT07075250 clinical landscape for Recurrent Platinum-Resistant Ovarian Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Huperzine A in Dementia due to Alzheimer's disease (disorder): NCT07066826 Clinical Landscape Report 2026
16 October 2026
NCT07066826 clinical landscape for Dementia due to Alzheimer's disease (disorder): endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
SHR-1139 in Psoriasis: NCT07078695 Clinical Landscape Report 2026
16 October 2026
NCT07078695 clinical landscape for Psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Methotrexate Sodium in Arthritis, Psoriatic: NCT07086924 Clinical Landscape Report 2026
16 October 2026
NCT07086924 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bevacizumab in Advanced Cervical Carcinoma: NCT07080216 Clinical Landscape Report 2026
16 October 2026
NCT07080216 clinical landscape for Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.